Pancreatic islets study may spur diabetes treatment advances

Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes.

VUMC team’s discovery could lead to new diabetes treatment

NIDDK renews Vanderbilt’s diabetes research grant

The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).

American Diabetes Association honors Granner’s achievements

Daryl Granner, M.D., professor of Molecular Physiology and Biophysics, emeritus, at Vanderbilt, has been recognized for outstanding achievements in diabetes research and training by the American Diabetes Association.

Making human beta cells reproduce

A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

Gifts highlight strong, lasting bonds between patients and healers

Sometimes saying thank you just isn’t enough.